Genetic tests that show high or low sensitivity to blood thinner (anticoagulant) drugs like warfarin (Coumadin) not only improve dosing accuracy but also reduce hospitalization by 31 percent, according to a new study just presented at the American College of Cardiology scientific sessions. Coumadin is often prescribed for people who have afib to prevent blood clots that can cause strokes.

Read more: Gene Test Improves Use of Coumadin (warfarin) for Stroke Prevention in Atrial Fibrillation

Mellanie True Hills Bio

We value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.

Expert Bio HERWriter

Mellanie True Hills

View Profile Send Me a Message

Mellanie True Hills is a heart disease survivor and the author of the multiple award-winning book, “A Woman's Guide ...

http://www.stopafib.org/

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Do you really want to post anonymously?

Are You a Member? Log InConnect your comment to your member profile. It only takes a second! Not a Member? Join Now!You'lll be automatically notified when someone else comments on your post.

Tell us what you think Write your comment here *

Receive email notifications of new comments Email Addresss

Sign me up for EmpowHER's FREE Newsletter!

Type in the characters above *

By hitting submit, you agree to EmpowHER's terms of service and privacy policy